Mutations in α-Syn, PRKN, PINK1, DJ-1, LRRK2, and GBA can be detected by analysis of global gene expression with DNA microarrays (Table 5) which has been performed in the peripheral blood of PD patients [303,304] and successfully serve as genetic biomarkers. This evidence concerns the gene LRRK2 and Parkinson disease.